Aspiriant, an independent wealth management firm in the US, has launched the Aspiriant Risk-Managed Global Equity (RGE) Fund, a global equity mutual fund that will attempt to outperform global equity benchmarks while limiting losses during times of intense market volatility.
This is the first registered mutual fund developed by Aspiriant. Initially, the RGE Fund will be available exclusively to Aspiriant investment advisory clients.
"The fund is a public equity solution for individual client portfolios," says Jason Thomas (pictured), chief investment officer of Aspiriant who will oversee the sub-advisers in the fund. "In addition to a quantitative equity strategy, the fund applies a number of sophisticated risk management techniques previously unavailable to individual investors at a reasonable cost. We believe these strategies to positively impact performance and simultaneously ease our clients’ anxiety about staying invested in equities during times of huge market swings."
The fund will be broadly diversified, with allocations to US, developed international, and emerging equity markets. The fund will attempt to outperform the broad equity market through active stock selection while offering two additional options-based strategies, one designed to generate additional income and the other to limit losses during a bear market.
"Aspiriant has the scale, investment sophistication and innovative thinking to bridge the divide between institutional and high net worth investors. We hope to redefine the term ‘smart money’,” says Thomas. "And by combining these strategies in a single fund, we expect to execute them in a manner that is efficient and cost effective, while providing our clients the transparency and liquidity available only in registered mutual funds."
